warning: Notice: Do not use if you have or develop diarrhea, loose stools or abdominal pain because rhubarb may worsen these conditions and be harmful to your health. Consult your physician if you have frequent diarrhea.
other: Also known as Siberian rhubarb root
other: Estrovera's key ingredients, ERr 731, has been used safely and effectively for over 20 years and is supported by clinical studies. Estrovera provides relief for multiple menopausal symptoms, including hot flashes, sleep disturbances, mood swings, irritability, anxiety, and sexual problems.
claim: Visit MetaDispensary.com for additional information.
other: Directions: Take one tablet with food and a glass of water once daily at the same time of day or as directed by your healthcare practitioner.
other: This product is non-GMO, gluten-free, and vegetarian.
other: This product is non-GMO, gluten-free, and vegetarian.
warning: Caution: Do not use if pregnant or nursing. If taking medication, consult your healthcare practitioner before use.
other: Storage: Keep tightly closed in a cool, dry place.
other: These statements have not been evaluated by the Food and Drug Administration. This product is not included to diagnose, treat, cure, or prevent any disease.
other: Highly efficacious
Formulated with ERr 731, which has shown up to 83% reduction in menopausal symptoms
Percentages are estimated and not included in the studies. For more information please visit MetaDispensary.com.
Exceptional safety profile
ERr 731 recommended by healthcare professionals in Europe since 1993
This estimate ratio is not included in the publication of cumulative results of a 12-week study followed by 2 48-week observation studies (OS). It is calculated from the mean change of the MRS II total score of 5.7 at the end of the first 48-week OS divided by the baseline score of 34. There was no change in total score from the end of the first OS to the end of the second OS. These results are from the ERr 731 subgroup only, which was administered ERr 731 daily for a total of 108 weeks. This calculation does not take into account some changes in study population over time.
other: 83% decrease in daily hot flashes
ERr 731 delivers non-hormonal hot flash relief, with up to an 83% decrease in daily hot flashes and other menopausal symptoms
Kaszkin-Bettag M, Ventskovsky BM, Solskyy S, et al. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms. Altern Ther Health Med. 2009; 15(1):24-34.
claim: 12-week study of 112 perimenopausal women
ERr 731 subjects reported a significant decrease in the medium number of daily hot flashes compared to subjects taking placebo
claim: Number of Daily Hot Flashes
Baseline
Placebo 12
ERr 731 12
12 Weeks
Placebo 13
ERr 731 2
Label facts as declared by the manufacturer to the NIH Dietary Supplement Label Database (DSLD), not independently
lab-tested. This page reports what the label says; it does not rate, score, or recommend this product.